reduce basal insulin dose when starting glp-1 receptor agonist GLP−1 agonists for the treatment of obesity: Role as a promising approach GLP-1 Receptor Agonists as Treatments
Description
Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.
Four weeks ago, I wrote about my decision to undertake a weight-loss journey using a GLP-1 (a semagl
Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes
